OCDX News
Archived Headlines
- US IPO Week Ahead: Diverse 8 IPO week features 3 billion-dollar deals 01/22/21
- Carlyle LBO Ortho Clinical Diagnostics sets terms for $1.5 billion IPO 01/19/21
- US IPO Weekly Recap: The new year kicks off with 2 biotech IPOs and a tidal wave of SPACs 01/08/21
- Carlyle LBO Ortho Clinical Diagnostics files for an estimated $800 million IPO 01/04/21
2021's biggest IPOs are some of the biggest losers
In 2021, 27 IPOs raised $1 billion or more, the biggest-ever crop of billion-dollar IPOs in a single year. While the largest issuers have historically outperformed the broader group average, that is not the case for 2021 IPOs. Of last year's 27 billion-dollar...read more
Updated: Renaissance Capital's 1Q 2021 US IPO Market Review
Explosive IPO Market Delivers the Busiest Quarter Since 2000 The US IPO market produced its busiest quarter in over two decades, with 100 IPOs raising $39.2 billion. Fueled by momentum from...read more
US IPO Weekly Recap: January closes out with 3 billion-dollar deals in an 8 IPO week
The first month of 2021 closed out with eight IPOs, 24 SPACs, and one postponement. Three issuers raised more than $1 billion, bringing the count of billion-dollar US IPOs in January to six, the most in a single month ever. Just one IPO submitted an initial...read more
Ortho Clinical Diagnostics prices IPO below the range at $17
Ortho Clinical Diagnostics, a Carlyle-backed global provider of in vitro diagnostic products, raised $1.3 billion by offering 76 million shares at $17, below the range of $20 to $23. The company increased its offering by 6.0 million shares (9%). At pricing,...read more